Tubal, Zyrahlyn M.
HRN: 28-24-58 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/03/2026
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
06/03/2026
06/07/2026
PO
2ml
BID
Measle Pneumonia
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes